AbC-19™ Rapid Test
Abingdon HealthThe AbC-19™ Rapid Test is a single use rapid test for the detection of IgG antibodies in response to the SARS-CoV-2 virus or following vaccination.
Improving health through innovation in rapid diagnostics Abingdon Health is a technology-enabled lateral flow diagnostics company providing innovative rapid testing solutions to a multi-industry, global client base. Abingdon Health provides specialist lateral flow development and smartphone reader solutions alongside Europe’s largest lateral flow manufacturing capacity. Abingdon Health takes projects from initial concept through scale-up and into high-volume manufacturing, in addition to accommodating clients looking to transfer their rapid test from third-party developers or manufacturers. Our multi-disciplinary team approach integrates technical, commercial, quality & regulatory expertise. This is underpinned by rapid test technology innovation, best-in-class automation and a commitment to develop, manufacture and commercialise quality assays and mHealth platforms. Supporting a healthier future Abingdon Health strongly believes by manufacturing rapid testing solutions while supporting our employees and communities contributes positively to society’s health and wellbeing. The diagnostic tests and data solutions we produce streamlines testing and speeds up treatment decision-making. Our commitment to employee development and empowerment supports the futures of our team members and their families. Working with our charity partners and responsibly managing our impact on the environment helps to give back to the communities we work and live in. Also, by forming long-term partnerships across multiple sectors we are pleased to be contributing to the One Health movement. Our goal Increase the migration of testing from the laboratory to point-of-care or in-the-field testing to improve health outcomes for humans, animals and plants.
The AbC-19™ Rapid Test is a single use rapid test for the detection of IgG antibodies in response to the SARS-CoV-2 virus or following vaccination.
Seralite® is a rapid diagnostic device for the quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light chains (FLCs) in serum. The assay utilises highly specific, anti-K and anti-λ monoclonal antibodies which are conjugated to gold particles and incorporated into a simple to use lateral flow device. Utilising a portable reader the results are presented on screen in mg/L along with the calculated K/λ rati…
Rapid nucleic acid detection post isothermal amplification for decentralised, point of care molecular testing